Cargando…
Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
Neoplastic tissue exhibits high glucose utilization and over-expression of glucose transporters (GLUTs) and hexokinases (HKs), which can be imaged by (18)F-Fluorodeoxyglucose-positron emission tomography (FDG-PET). The aim of the present study was to investigate the expression of glycolysis-associat...
Autores principales: | Binderup, Tina, Knigge, Ulrich Peter, Federspiel, Birgitte, Sommer, Peter, Hasselby, Jane Preuss, Loft, Annika, Kjaer, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665527/ https://www.ncbi.nlm.nih.gov/pubmed/26824929 http://dx.doi.org/10.3390/diagnostics3040372 |
Ejemplares similares
-
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
por: Nielsen, Kirstine, et al.
Publicado: (2020) -
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
por: Ilett, Emma Elizabeth, et al.
Publicado: (2015) -
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018) -
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020) -
Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)